VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already ...

In the development of therapeutic monoclonal antibodies (mAbs), it is crucial to select lead candidates with optimal biological and pharmaceutical properties. Binding affinity is a significant factor ...

In this Tech Blast episode supported by Sartorius (Göttingen, Germany), we speak with Manager of Applications Development, David Apiyo (right), about epitope binning, why it’s performed and the best ...

Epitope binning is an important step towards selecting the best monoclonal antibody for a specific therapeutic purpose as it allows researchers to narrow down the number of candidates by assessing ...

Rapid Novor Inc. and MAbSilico announced that they have partnered to provide the world's first AI-driven HDX-MS epitope mapping service for antibody development. By seamlessly integrating experimental ...

“Antibodies with unique epitopes that may offer mechanistically differentiated modes of action and intellectual property opportunities are highly desirable as therapeutics,” explains Yasmina Noubia ...

Monoclonal antibodies (mAbs) are one of the most successful therapeutic drug classes, generating lucrative sales for the pharmaceutical industry. In 2016, more than 20 therapeutic antibodies gained ...

VICTORIA, BC / ACCESSWIRE / April 22, 2024 / ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, has recently announced an expansion of its already ...